I01 CX001822/CX/CSRD VA/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2020	1
2022	1
2023	1
2024	0

Page 1

XDec-CHI reveals immunosuppressive interactions in pancreatic ductal adenocarcinoma.

LaPlante EL, Liu D, Petrosyan V, Yao Q, Milosavljevic A. LaPlante EL, et al. iScience. 2022 Sep 29;25(10):105249. doi: 10.1016/j.isci.2022.105249. eCollection 2022 Oct 21. iScience. 2022. PMID: 36274954 Free PMC article.

Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy.

Marin-Muller C, Li D, Lü JM, Liang Z, Vega-Martínez O, Crawford SE, Estes MK, Fisher WE, Chen C, Yao Q. Marin-Muller C, et al. Pharmaceutics. 2023 Jul 28;15(8):2038. doi: 10.3390/pharmaceutics15082038. Pharmaceutics. 2023. PMID: 37631252 Free PMC article.

A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk.

Liu D, Zhou D, Sun Y, Zhu J, Ghoneim D, Wu C, Yao Q, Gamazon ER, Cox NJ, Wu L. Liu D, et al. Cancer Res. 2020 Oct 15;80(20):4346-4354. doi: 10.1158/0008-5472.CAN-20-1353. Epub 2020 Sep 9. Cancer Res. 2020. PMID: 32907841 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year